BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

936 related articles for article (PubMed ID: 9864405)

  • 1. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy?
    Lee P; de Bree R; Brokx HA; Leemans CR; Postmus PE; Sutedja TG
    Lung Cancer; 2008 Dec; 62(3):309-15. PubMed ID: 18486989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
    Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case report of resected double primary lung cancers in the same one segment].
    Sugita T; Yasuda R; Magara T; Nishikawa T; Matsumoto M
    Kyobu Geka; 1991 Feb; 44(2):155-7. PubMed ID: 1848914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient.
    Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):225-7. PubMed ID: 17301532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of doses.
    Collery P; Morel M; Desoize B; Millart H; Perdu D; Prevost A; Vallerand H; Pechery C; Choisy H; Etienne JC
    Anticancer Res; 1991; 11(4):1529-32. PubMed ID: 1660690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunomodulating role of indomethacin in the chemoradiation treatment of inoperable patients with lung cancer].
    Kas'ianenko IV; Pivniuk VM; Lisitsa AM; Kovalenko NA; Bagirian MA
    Vopr Onkol; 1992; 38(10):1183-7. PubMed ID: 1343143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of synchronous lung cancers.
    Ferguson MK; DeMeester TR; DesLauriers J; Little AG; Piraux M; Golomb H
    J Thorac Cardiovasc Surg; 1985 Mar; 89(3):378-85. PubMed ID: 3974273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy and integrated treatment in carcinoma of the lung].
    Bottero G; Novella V; Spinoglio G
    Minerva Med; 1988 Apr; 79(4):275-9. PubMed ID: 2835711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [International consensus for lung cancer treatment].
    Naruse I; Saijo N
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():451-9. PubMed ID: 9369922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of surgery in the combined management of small cell bronchial carcinoma.
    Salzer GM; Müller LC; Frommhold H; Huber H; Lechleitner M
    Thorac Cardiovasc Surg; 1986 Oct; 34(5):326-9. PubMed ID: 2431506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postoperative chemotherapy of pathological stage I non-small cell carcinoma of the lung].
    Kikuchi K; Ogata T
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):24-9. PubMed ID: 3002284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of peripheral small cell lung cancer.
    Urschel JD
    Chest Surg Clin N Am; 1997 Feb; 7(1):95-103. PubMed ID: 9001758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic procedure in patients with suspected lung cancer. Results of combined evaluation by thoracic surgery and pulmonary medicine specialists].
    Ringbaek TJ; Borgeskov S; Lange P; Viskum K
    Ugeskr Laeger; 1998 Jan; 160(2):166-9. PubMed ID: 9458702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
    Uke M; Rekhi B; Ajit D; Jambhekar NA
    Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of metallothionein in human non-small-cell lung carcinomas following chemotherapy.
    Matsumoto Y; Oka M; Sakamoto A; Narasaki F; Fukuda M; Takatani H; Terashi K; Ikeda K; Tsurutani J; Nagashima S; Soda H; Kohno S
    Anticancer Res; 1997; 17(5B):3777-80. PubMed ID: 9427779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non-small cell type but not of the small cell type.
    Ariza A; Mate JL; Isamat M; López D; Von Uexküll-Güldeband C; Rosell R; Fernández-Vasalo A; Navas-Palacios JJ
    J Pathol; 1995 Dec; 177(4):363-8. PubMed ID: 8568590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.